Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?Zacks Investment Research • 02/18/26
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with HypoparathyroidismGlobeNewsWire • 02/04/26
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/26
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 GrowthZacks Investment Research • 01/06/26
Here's Why You Should Retain OPKO Health Stock in Your Portfolio NowZacks Investment Research • 12/09/25
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/19/25
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/29/25
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial ResultsGlobeNewsWire • 10/29/25
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesPRNewsWire • 09/15/25
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial ResultsGlobeNewsWire • 07/31/25
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity SymposiumGlobeNewsWire • 06/25/25